Medicare coverage of weight loss drugs would cost $35B
Expanding Medicare coverage of costly weight loss drugs could come at a steep cost for the federal government. Allowing Medicare to cover obesity medications would increase federal spending ...
More than half of independent pharmacies are considering not stocking the first 10 drugs that were subject to Medicare price ...
Medicare is prohibited by law from covering GLP-1 drugs for weight loss. But many beneficiaries can access the drugs anyway.
Total direct federal costs of covering AOMs would increase from $1.6 billion in 2026 to $7.1 billion in 2034, CBO finds.
If Medicare were to start covering popular weight loss drugs such as Wegovy and Zepbound, it could increase federal spending ...
Men, Baby Boomers, and postgraduate degree-holders were among those most likely to say they wouldn’t choose medication over ...